A
ABCL
Abcellera Biologics Inc.
3.520
+0.010+0.28%After Hours: 3.540 +0.020 +0.57%19:51 04/02 EDT
OPEN/PREV CLOSE3.430/3.510
TODAY RANGE3.410-3.625
VOL3.49M
MARKET CAP1.07B
52 WEEK RANGE1.891-6.52
AVG VOL (3M)3.92M
% TURNOVER1.15%
TURNOVER--
P/E (TTM)-7.1807
% RANGE6.13%
EPS(TTM)-0.4902
P/E(FORWARD)-4.8889
P/B1.094
BVPS3.217
DIVIDEND--
P/S14.09
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP824.20M
SHARES OUTSTANDING303.16M
NEXT EARNINGS05/06-05/11
FREE FLOAT234.15M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
Is AbCellera (ABCL) Quietly Rewriting Its Investment Story With Cash Reserves And Advancing Trials?
Seeking Alpha·03/26 10:08
AbCellera: Dart-Board Approach Reflects Trading Premium (Upgrade)
Seeking Alpha·03/18 00:54
Tracking Baker Brothers Portfolio - Q4 2025 Update
Simply Wall St·03/10 09:17
A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss
TipRanks·03/03 02:07
Major Investor Quietly Ramps Up Stake in AbCellera Biologics
Reuters·03/02 19:17
Thermopylae Holdings Ltd. Acquires AbCellera Biologics Common Shares
Simply Wall St·02/28 13:25
AbCellera (ABCL) Is Up 18.8% After Pivoting To Clinical Stage And Filing Share Offering
TipRanks·02/28 02:07
Insiders Quietly Double Down on AbCellera Biologics in Bold Buying Spree
Reuters·02/27 21:28
Thermopylae Holdings Ltd. Acquires AbCellera Biologics Common Shares
Reuters·02/27 19:49
AbCellera CFO Andrew Booth Acquires Common Shares
Simply Wall St·02/27 06:37
A Look At AbCellera Biologics (ABCL) Valuation After Narrower Losses And Pipeline Progress
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.